# OrSense NBM-200 selected by Central Blood Bank of Catalonia

OrSense Ltd. announced that its NBM-200 non-invasive hemoglobin measurement device was selected by Banc de Sang I Teixits, the central blood bank of Catalonia, under a two-year contract with three one-year extension options.

- Type: Contract
- Announced: 2019-07-11
- Where: Catalonia, Spain
- Status: announced
- Products: NBM-200 non-invasive hemoglobin measurement device
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [OrSense](https://endata.com/companies/40596.md)
- [Banc de Sang I Teixits](https://endata.com/companies/40597.md) (customer)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/orsense-nbm-200-non-invasive-hemoglobin-device-selected-by-the-central-blood-bank-of-catalonia-300883949.html), 2019-07-12: "We are very happy with the Banc de Sang's decision to select the NBM-200 again."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.